Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

18.13 -0.47 (-2.53%)
Streaming Delayed Price Updated: 1:02 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
My 2024 Financial Resolution: Buying More of These 3 Stocks
These stocks are still screaming buys for my long-term portfolio. 
Via The Motley Fool
1 Healthcare Stock to Buy Hand Over Fist Going Into 2024
Hims & Hers Health is growing at an unprecedented rate. 
Via The Motley Fool
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
From Hims & Hers Health, Inc.
Via Business Wire
It Is Time To Buy Hims & Hers Stock
Hims & Hers is a pharmaceutical marketing, product, and distribution firm with a telehealth component. 
Via Talk Markets
Is Hims & Hers Stock a Buy Now?
Investors may be overlooking an incredible growth opportunity with Hims & Hers stock. 
Via The Motley Fool
This Growth Stock Could 10x in 10 Years
This emerging consumer healthcare company could compound at more than 25% annually. 
Via The Motley Fool
Hims & Hers earnings highlight expanded personalized treatments
E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products 
Via MarketBeat
5 Telehealth Stocks That Have Nothing But Upside
Dive into the dynamic world of top telehealth stocks. Discover our expert analysis on the gems shaping the future of digital healthcare. 
Via InvestorPlace
My Take: 4 Strong Growth Stocks to Buy This Week
Be thankful for Wall Street's discounts on these potential market-beating stock ideas. 
Via The Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less Than $50
These rapidly expanding companies could make you richer, even with a minimal investment. 
Via The Motley Fool
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy. 
Via InvestorPlace
Top 5 Health Care Stocks That May Collapse In November
As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Is Hims & Hers Health Stock a Buy After Strong Earnings?
The company reported another good quarter and announced a buyback. Is HIMS stock a buy? 
Via The Motley Fool
MSP Recovery, Uber, Hims & Hers Health, Celsius, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Hims & Hers Health Q3 Results Mixed But FY23 Revenue Guidance Raised, $50 Million Share Buyback
Hims & Hers Health, Inc. (NYSE: HIMS) shares are trading higher in Monday's after-hours session after the company reported third-quarter earnings. 
Via Benzinga
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
From Hims & Hers Health, Inc.
Via Business Wire
5 Companies Worth Watching Closely This Earnings Week
A couple of pandemic darlings are reporting earnings this week. Here's what I'm expecting. 
Via The Motley Fool
Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services
From Hims & Hers Health, Inc.
Via Business Wire
Where Will Hims & Hers Health Be in 5 Years?
The stock is cheap, but is Hims & Hers a good investment to add to your portfolio? 
Via The Motley Fool
Hims & Hers Names Khobi Brooklyn As Chief Communications Officer
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023
From Hims & Hers Health, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Growth Stocks That Can Rocket 98% to 108% Higher, According to Wall Street
The analysts who follow these stocks have some big expectations for the year ahead. 
Via The Motley Fool
Is Hims & Hers Health Stock a Buy Now?
Share prices are down 50% since touching $12 a share in May of this year. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.